Hydroxychloroquine reduces COVID-19 risk: real-time meta analysis of 424 studies
424 HCQ COVID-19 controlled studies. 66% improvement for early treatment, p < 0.0001. 22% improvement for late treatment, p < 0.0001. c19hcq hcqmeta
c19early: COVID-19 treatment analysis